A nightly sleeping aid could be moonlighting as a guardian of your future sight.
As the specter of age-related macular degeneration (AMD)—a progressive and currently incurable condition that, without treatment, can result in permanent vision loss—looms, researchers have stumbled upon an ally in the battle against blindness: melatonin.
Large US Study Findings Show Reduced Risk of AMD
Researchers analyzed data from the TriNetX database, a national network of electronic health records, that covered electronic medical records of more than 121,500 people ages 50 or older across the United States with no history of AMD. The participants had used melatonin medication in the period spanning November 2008 to November 2023.
George Citroner
Author
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.
